Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia

Genes Chromosomes and Cancer

Volumn 19, Issue 4, 1997, Pages 250-255

  Gaidano, Gianluca ^a,b   Pastore, Cristina ^a   Santini, Valeria ^c   Nomdedeu, Josep ^d   Gamberi, Barbara ^e   Capello, Daniela ^b   Vischia, Federico ^b   Resegotti, Luigi ^f   Mazza, Umberto ^b   Rossi Ferrini, Pierluigi ^c   Lo Coco, Francesco ^g   Saglio, Giuseppe ^a,h  

^a SAN LUIGI GONZAGA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e Columbia University ^*  (United States)

^f Divisione di Ematologia   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLAST TRANSFORMATION; CLINICAL ARTICLE; GENE ACTIVATION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTHEMIA; TUMOR GROWTH;

ADULT; AGED; BLAST CRISIS; BLOTTING, SOUTHERN; DISEASE PROGRESSION; DNA; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA PROBES; DNA, NEOPLASM; FEMALE; GENES, P53; GENES, RAS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SEQUENCE ANALYSIS, DNA; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 0030755671     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199708)19:4<250::AID-GCC7>3.0.CO;2-W     Document Type: Article

References (45)

1. Arlin ZA, Silver RT, Bennet JM (1990) Blastic phase of chronic myeloid leukemia (blCML): A proposal for standardization of diagnostic and response criteria. Leukemia 4:755-757.
2. Ballerini P, Gaidano G, Gong JZ, Tassi Y, Saglio G, Knowles DM, Dalla-Favera R (1993) Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 81:166-176.
3. Belucci S, Janvier M, Tobelen G, Flandrin G, Charpak Y, Berger R, Boiron S (1986) Essential chrombocychemias: Clinical evolutionary and biological data. Cancer 58:2440-2447.
4. Berger R, Bernheim A, Le Coniat M, Vecchione D, Flandrin G, Dresch C, Najean Y (1984) Chromosome studies in polycythemia vera patients. Cancer Genet Cytogenet 12:217-223.
5. Berlin N (1975) Diagnosis and classification of the polycythemias. Semin Hematol 12:339-351.
6. Bos JL (1989) Ras oncogenes in human cancer: A review. Cancer Res 49:4682-4689.
7. Brathwaitc O, Bayona W, Newcomb EW (1992) p53 mutations in C57BL/6J murine thymic lymphomas induced by γ-irradiation and N-methylnitrosourea. Cancer Res 52:3791-3795.
8. Cervantes F, Tassies D, Salgado C, Rovira M, Pereira A, Rozman C (1991) Acute transformation in nonleukemic myeloproliferative disorders: Actuarial probability and main characteristics in a series of 218 patients. Acta Hematol 85:124-127.
9. Chievitz E, Thiede T (1962) Complications and causes of death in polycythemia vera. J Intern Med 172:513-520.
10. Dameshek W (1951) Some speculations on the mycloproliferative syndromes. Blood 6:372-375.
11. Feinberg AP, Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
12. Fickers M, Speck B (1974) Thrombocythemia: Familial occurrence and transition into blastic crisis. Acta Haematol 51:257-265.
13. Frei-Lahr D, Barton JC, Hoffman R, Burkett LL, Prcharl JT (1984) Blastic transformation of essential thrombocythemia: Dual expression of myelomonoblastic/megakaryoblastic phenotypes. Blood 63:866-872.
14. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles, DM, Dalla-Favera R (1991) p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA, 88:5413-5417.
15. Gaidano G, Guerrasio A, Serra A, Carozzi F, Rege Cambrin G, Petroni D, Saglio G (1993) Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders. Leukemia 7:946-953.
16. Gaidano G, Serra A, Guerrasio A, Rege-Cambrin G, Mazza U, Saglio G (1994) Genetic analysis of p53 and RB1 tumor suppressor genes in blast crisis of chronic myeloid leukemia. Ann Hematol 68:3-7.
17. Geller SA, Shapiro E (1982) Acute leukemia as a natural sequel to primary thombocythemia. Am J Clin Pathol 77:353-356.
18. Groupe Français de Cytogénétique Hématologique (1988). Cytogenetics of acutely transformed myeloproliferative syndromes without a Philadelphia chromosome. Cancer Genet Cytogenet 32:157-168.
19. Hehlmann R, Jahn M, Baumann B, Köpeke W (1988) Essential thrombocythemia: clinical characteristics and course of 61 cases. Cancer 61:2487-2496.
20. Hoffman R, Boswell HS (1995) Polycythemia vera, In Hoffman R, Benz EJ, Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology: Basic Principles and Practice. New York: Churchill Livingstone, pp 1121-1142.
21. Hoffman R, Silverstein MN, Hromas R (1995) Primary thrombocythemia. In Hoffman R, Benz EJ, Jr., Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology: Basic Principles and Practice. New York: Churchill Livingstone, pp 1174-1184.
22. Jannsen JWG, Steenvoorden ACM, Lyons J, Anger B, Bohlke JU, Bos JL, Seliger H, Bartram CR (1987) RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodisplastic syndromes. Proc Natl Acad Sci USA 84:9228-4232.
23. Landaw SA (1986) Acute leukemia in polycythemia vera. Semin Hematol 23:156-165.
24. Lawrence JH, Winchell HS, Donall WG (1964) Leukemia in polycythemia vera: Relationship to splenic myeloid metaplasia and therapeutic radiation dose. Ann Intern Med 70:763-771.
25. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D (1994) Microsatellite alterations as clonal markers for the detection of human cancers. Proc Natl Acad Sci USA 91:9871-9875.
26. Mertens F, Johansson B, Heim S, Kristofferson U, Mitelman F (1991) Karyotypic patterns in chronic myeloproliferative disorders: Report on 74 cases and review of the literature. Leukemia 5:214-220.
27. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 16:15.
28. Mitelman F (1991) Catalog of Chromosome Aberrations in Cancer, Fourth Edition. New York: Wiley-Liss, Inc.
29. Modan B (1975) Inter-relationship between polycythemia vera, leukemia and myeloid metaplasia. Clin Haematol 4:427-439.
30. Modan B, Lilienfeld AM (1965) Polycythemia vera and leukemia - the role of radiation: Study of 1,122 patients. Medicine 44:305-312.
31. Murphy S, Iland H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group. Semin Hematol 23:117-182.
32. Najean Y, Deschamps A, Dresch C, Daniel MT, Rain JD, Arrago JP (1988) Acute leukemia and myelodysplasia in polycythemia vera: A clinical study with long-term follow up. Cancer 61:89-95.
33. Neri A, Fracchiolla NS, Radaelli F, Boletini A, Ribera S, Migliorini C, Trecca D, Maiolo AT (1996) p53 tumor suppressor gene and ras oncogenes: Molecular analysis in the chronic and leukaemic phases of essential thrombocythemia. Br J Haematol 93:670-673.
34. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83.
35. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
36. Pastore C, Nomdedeu J, Volpe G, Guerrasio A, Rege Cambrin G, Parvis G, Pautasso M, Daglio C, Mazza U, Saglio G, Gaidano G (1995) Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders. Genes Chromosom Cancer 14:106-111.
37. Rege-Cambrin G, Mecucci C, Tricot G, Michaux J-L, Louwagie A, Van Howe W, Francart H, Van Den Berghe HA (1987) chromosomal profile of plycythemia vera. Cancer Genet Cytogenet 25:233-245.
38. Sambrook J, Fritsch E, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
39. Serra A, Gaidano G, Revello D, Guerrasio A, Ballerini P, Dalla Favera R, Saglio G (1992) A new TaqI polymorphism in the p53 gene. Nucl Acid Res 20:928.
40. Sessarego M, Deferrari R, Dejana AM, Rebuttato AM, Fugazza G, Salvidio E, Ajmar F (1989) Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. Cancer Genet Cytogenet 43:57-65.
41. Tanzer J (1994) Clonality and karyotype studies in polycythemia vera. Nouv Rev Fr Hematol 36:167-172.
42. Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM (1985) Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 315:340-343.
43. Vardiman JW (1992) Chronic myelogenous leukemia and the myeloproliferative disorders. In Knowles DM (ed): Neoplastic Hematopathology. Baltimore: Williams and Wilkins, pp 1405-1438.
44. Volpe G, Gamberi B, Pastore C, Roetto A, Pautasso M, Parvis G, Camaschella C, Mazza U, Saglio G, Gaidano G (1996) Analysis of microsatellite instability in chronic lymphoproliferative disorders. Ann Hematol 72:67-71.
45. Wasserman LR (1954) Polycythemia vera - its course and treatment: Relation to myeloid metaplasia and leukemia. Bull NY Acad Med 3:343-353.